Safety and Adverse Effect Management

Panelists discuss how managing adverse effects of tardive dyskinesia (TD) medications is central to long-term success. Common issues such as somnolence, fatigue, or mood changes can affect adherence if not addressed proactively. Pharmacists provide vital counseling on what to expect and how to mitigate these effects.

Panelists discuss how close communication between pharmacists, prescribers, and patients helps detect early warning signs of adverse reactions or drug-drug interactions. Monitoring becomes especially important for patients with psychiatric comorbidities or those on complex regimens.

Panelists discuss how pharmacists’ accessibility allows for real-time feedback and intervention when patients report tolerability issues. This collaborative approach minimizes treatment discontinuation and supports sustained symptom control.